NasdaqCM - Delayed Quote USD
60 Degrees Pharmaceuticals, Inc. (SXTPW)
0.0500
-0.0051
(-9.26%)
At close: May 20 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 300k | 400k | 1.4M | 2.2M |
| Low Estimate | 300k | 400k | 1.4M | 2.2M |
| High Estimate | 300k | 400k | 1.4M | 2.2M |
| Year Ago Sales | 124.97k | 135.29k | 607.57k | 1.4M |
| Sales Growth (year/est) | 140.06% | 195.66% | 130.43% | 57.14% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SXTPW | -- | -- | -- | -- |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Related Tickers
IVEVF Inventiva S.A.
2.2800
0.00%
JSPRW Jasper Therapeutics, Inc.
0.0867
-0.57%
IVA Inventiva S.A.
3.2988
+4.39%
JSPR Jasper Therapeutics, Inc.
5.04
+0.40%
ROIV Roivant Sciences Ltd.
11.04
+1.85%
ARWR Arrowhead Pharmaceuticals, Inc.
16.29
+3.49%
VXRT Vaxart, Inc.
0.5080
+1.64%
CRSP CRISPR Therapeutics AG
39.25
+1.47%
PTIX Protagenic Therapeutics, Inc.
6.88
-38.02%